XML 43 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders Equity (Tables)
9 Months Ended
Sep. 30, 2025
Stockholders Equity  
Schedule of management stock compensation

Market capitalization

for 30

consecutive days

 

 

Consulting agreement

CEO resigned on

October 1, 2025

(Shares)

 

 

Consulting agreement

Director

(Shares)

 

 

Employment agreement

COO

(Shares)

 

$

120,000,000

 

 

 70,000 series C preferred stock

 

 

 70,000 series C preferred stock

 

 

 

-

 

$

150,000,000

 

 

 70,000 series C preferred stock

 

 

 70,000 series C preferred stock

 

 

37,500 common stock

 

$

200,000,000

 

 

 70,000 series C preferred stock

 

 

 70,000 series C preferred stock

 

 

37,500 common stock

 

$

250,000,000

 

 

 70,000 series C preferred stock

 

 

 70,000 series C preferred stock

 

 

37,500 common stock

 

$

300,000,000

 

 

 

-

 

 

 

-

 

 

37,500 common stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value ($)

 

 

$1,932,000

 

 

$3,165,000

 

 

$1,740,000

 

Schedule of assumptions used for fair value compensation

2025

 

Derived service period

 

0.51 – 0.78 year

 

Risk-free interest rate

 

3.65 - 3.97

Stock price at valuation date

$

5.89 - 12.00

 

Expected average volatility

 

108.5 - 151.0

First Capitalization Thresholder per share price

$

6.85 - 14.28

 

Second Capitalization Thresholder per share price

8.56 - 19.02

 

Third Capitalization Thresholder per share price

$

11.42 - 23.82

 

Fourth Capitalization Thresholder per share price

$

 14.27 - 28.56

 

Schedule of assumptions of warrants

 

 

September 30,

 

 

 

2025

 

Expected term

 

5.00 years

 

Expected average volatility

 

49.0% - 228

Risk-free interest rate

 

3.82% - 4.29

Expected dividend yield

 

 

-

 

Summary of warrants activity

 

 

Warrants Outstanding

 

 

 Weighted Average

 

 

 

 

 

 

Weighted

 

 

Remaining

 

 

 

Shares

 

 

Average Exercise Price

 

 

Contractual life (in years)

 

 

 

 

 

 

 

 

 

 

 

Outstanding, December 31, 2024

 

 

270,010

 

 

$0.50

 

 

 

4.61

 

Granted

 

 

2,434,324

 

 

 

3.15

 

 

 

5.03

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Canceled

 

 

(778,566)

 

 

0.43

 

 

 

4.65

 

Outstanding, September 30, 2025

 

 

1,925,768

 

 

$4.22

 

 

 

4.57

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable, September 30, 2025

 

 

1,925,768

 

 

$4.22

 

 

 

4.57